RNU6-803P

Across TCGA pan-cancer cohorts, RNU6-803P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-803P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-803P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-803P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

BLCA, ACC, and DLBC are the cancer types where RNU6-803P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.223	0.620	<.001	129	view →
ACC	DFS	Tertile	All	0.057	0.675	<.001	126	view →
DLBC	OS	Tertile	II,III,IV	0.099	0.731	.005	90	view →
STAD	OS	Tertile	II,III,IV	0.186	0.581	.014	18	view →
HNSC	DFS	Tertile	All	0.810	0.591	.014	18	view →
UCEC	DFS	Tertile	All	0.829	0.899	.040	6	view →
ESCA	OS	Tertile	All	0.432	0.711	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-803P–BLCA (DFS)

Open the BLCA breakdown →